Dynamic changes of alkaline phosphatase are strongly associated with PSA-decline and predict best clinical benefit earlier than PSA-changes under therapy with abiraterone acetate in bone metastatic castration resistant prostate cancer

Mikah P, Krabbe LM, Eminaga O, Herrmann E, Papavassilis P, Hinkelammert R, Semjonow A, Schrader AJ, Boegemann M (2016)

In: BMC Cancer, 16.

Research article (journal)

Proximal tubular secretion of creatinine by organic cation transporter OCT2 in cancer patients.

Ciarimboli G, Lancaster CS, Schlatter E, Franke RM, Sprowl JA, Pavenstädt H, Massmann V, Guckel D, Mathijssen RH, Yang W, Pui CH, Relling MV, Herrmann E, Sparreboom A (2012)

In: Clinical Cancer Research, 18(4).

Research article (journal)

Combined immunochemotherapy in selected patients with metastatic renal cell carcinoma: HLA class II genotype can help to predict response to therapy.

Bierer S, Hoffmeister I, Gerss J, Herrmann E, Wülfing C, Sibrowski W, Hertle L, Kelsch R (2011)

In: Journal of Immunotherapy, 34(2).

Research article (journal)

Validation of pre-cystectomy nomograms for the prediction of locally advanced urothelial bladder cancer in a multicentre study. Are we able to adequately predict locally advanced tumour stages before surgery? | Validierung von Präzystektomienomogrammen zur Vorhersage lokal fortgeschrittener Harnblasenkarzinome in einer multizentrischen Studie. Können wir lokal fortgeschrittene Tumorstadien präoperativ ausreichend sicher vorhersagen?

May M, Burger M, Brookman-May S, Otto W, Peter J, Rud O, Fritsche H-M, Bolenz C, Trojan L, Herrmann E, Michel MS, Wülfing C, Moritz R, Tiemann A, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Wieland WF, Gilfrich C, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Bretschneider-Ehrenberg P, Müller O, Zacharias M, Gunia S, Bastian PJ (2011)

In: Urologe A, 50(6).

Research article (journal)

Lymph node density affects cancer-specific survival in patients with lymph node-positive urothelial bladder cancer following radical cystectomy

May M, Herrmann E, Bolenz C, Tiemann A, Brookman-May S, Fritsche H-M, Burger M, Buchner A, Gratzke C, Wülfing C, Trojan L, Ellinger J, Tilki D, Gilfrich C, Höfner T, Roigas J, Zacharias M, Gunia S, Wieland WF, Hohenfellner M, Michel MS, Haferkamp A, Müller SC, Stief CG, Bastian PJ (2011)

In: European Urology, 59(5).

Research article (journal)

Publications

Contact

Top-Links

Dynamic changes of alkaline phosphatase are strongly associated with PSA-decline and predict best clinical benefit earlier than PSA-changes under therapy with abiraterone acetate in bone metastatic castration resistant prostate cancer Mikah P, Krabbe LM, Eminaga O, Herrmann E, Papavassilis P, Hinkelammert R, Semjonow A, Schrader AJ, Boegemann M (2016) In: BMC Cancer, 16. Research article (journal)
New tools for assessing the individual risk of metastasis in renal cell carcinoma. Herrmann E, Weishaupt C, Pöppelmann B, Hillgruber C, Pühse G, Krabbe LM, Feld M, Steinhoff M, Goerge T (2013) In: Clinical and Experimental Metastasis, 30(2). Research article (journal)
Proximal tubular secretion of creatinine by organic cation transporter OCT2 in cancer patients. Ciarimboli G, Lancaster CS, Schlatter E, Franke RM, Sprowl JA, Pavenstädt H, Massmann V, Guckel D, Mathijssen RH, Yang W, Pui CH, Relling MV, Herrmann E, Sparreboom A (2012) In: Clinical Cancer Research, 18(4). Research article (journal)
Hypothyroidism correlates with a better prognosis in metastatic renal cancer patients treated with sorafenib or sunitinib. Riesenbeck LM, Bierer S, Hoffmeister I, Köpke T, Papavassilis P, Hertle L, Thielen B, Herrmann E (2011) In: World Journal of Urology, 29(6). Research article (journal)
Combined immunochemotherapy in selected patients with metastatic renal cell carcinoma: HLA class II genotype can help to predict response to therapy. Bierer S, Hoffmeister I, Gerss J, Herrmann E, Wülfing C, Sibrowski W, Hertle L, Kelsch R (2011) In: Journal of Immunotherapy, 34(2). Research article (journal)
New clues for nephrotoxicity induced by ifosfamide: preferential renal uptake via the human organic cation transporter 2. Ciarimboli G, Holle SK, Vollenbröcker B, Hagos Y, Reuter S, Burckhardt G, Bierer S, Herrmann E, Pavenstädt H, Rossi R, Kleta R, Schlatter E (2011) In: Molecular pharmaceutics, 8(1). Research article (journal)
Validation of pre-cystectomy nomograms for the prediction of locally advanced urothelial bladder cancer in a multicentre study. Are we able to adequately predict locally advanced tumour stages before surgery? \| Validierung von Präzystektomienomogrammen zur Vorhersage lokal fortgeschrittener Harnblasenkarzinome in einer multizentrischen Studie. Können wir lokal fortgeschrittene Tumorstadien präoperativ ausreichend sicher vorhersagen? May M, Burger M, Brookman-May S, Otto W, Peter J, Rud O, Fritsche H-M, Bolenz C, Trojan L, Herrmann E, Michel MS, Wülfing C, Moritz R, Tiemann A, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Wieland WF, Gilfrich C, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Bretschneider-Ehrenberg P, Müller O, Zacharias M, Gunia S, Bastian PJ (2011) In: Urologe A, 50(6). Research article (journal)
Multicenter evaluation of the prognostic value of pT0 stage after radical cystectomy due to urothelial carcinoma of the bladder. May M, Bastian PJ, Burger M, Bolenz C, Trojan L, Herrmann E, Wülfing C, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Otto W, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Wieland WF, Fritsche HM (2011) In: BJU International, 108(8b). Research article (journal)
Lymph node density affects cancer-specific survival in patients with lymph node-positive urothelial bladder cancer following radical cystectomy May M, Herrmann E, Bolenz C, Tiemann A, Brookman-May S, Fritsche H-M, Burger M, Buchner A, Gratzke C, Wülfing C, Trojan L, Ellinger J, Tilki D, Gilfrich C, Höfner T, Roigas J, Zacharias M, Gunia S, Wieland WF, Hohenfellner M, Michel MS, Haferkamp A, Müller SC, Stief CG, Bastian PJ (2011) In: European Urology, 59(5). Research article (journal)
Influence of older age on survival after radical cystectomy due to urothelial carcinoma of the bladder: Survival analysis of a German multi-centre study after curative treatment of urothelial carcinoma of the bladder \| Einfluss des Alters auf das karzinomspezifische Überleben nach radikaler Zystektomie: Überlebensanalyse aus einer deutschen Multicenterstudie nach kurativer Therapie eines Urothelkarzinoms der Harnblase May M, Fritsche H-M, Gilfrich C, Brookman-May S, Burger M, Otto W, Bolenz C, Trojan L, Herrmann E, Michel MS, Wülfing C, Tiemann A, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Wieland WF, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Müller O, Bretschneider-Ehrenberg P, Zacharias M, Gunia S, Bastian PJ (2011) In: Urologe A, 50(7). Research article (journal)